Global Digital Biomarker Market TOC
North American Market Forecast
The digital biomarkers market in North America is poised to dominate 45% revenue share by 2037. The growth of the market can be attributed majorly to the surging cases of Alzheimer’s disease in the region. North America accounts for the vast majority of instances worldwide. Alzheimer's is one of the top ten leading causes of death and disability in the United States, according to the Centers for Disease Control and Prevention. According to The Fisher Centre for Alzheimer's Research Foundation, someone in the United States develops Alzheimer's disease every 65 seconds. Over 6 million people in the United States were living with Alzheimer's Disease in 2021.
Europe Market Statistics
The European digital biomarkers market is estimated to be the second largest by the end of 2037. The market is expanding rapidly as a result of increased government assistance in major European countries such as Germany, the United Kingdom, Spain, and Russia. Increased government initiatives promoting mHealth are also expected to open up new opportunities for regional manufacturers. Moreover, the government is also working to propel the adoption of digital health in the region. The government established the European Health Data Space (EHDS) in 2022, allowing people across Europe to control and use their health data in their own nation.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?